Blackstone's investment in NantPharma reported by Deal Pipeline

Blackstone's investment in NantPharma reported by Deal Pipeline

Deal Pipeline reported that corporate partners Philip Richter and Brian Mangino advised NantPharma and NantWorks, LLC in connection with Blackstone's US$125 million investment in NantPharma. Coverage also appeared on Law360 and in the Los Angeles Business Journal.

Additional Information
news-detail.inc